10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,727,865 | +53.0% | 405,524 | +107.1% | 0.05% | +52.9% |
| Q2 2023 | $10,934,030 | -4.4% | 195,810 | -4.5% | 0.03% | -17.1% |
| Q1 2023 | $11,434,105 | -42.2% | 204,949 | -62.3% | 0.04% | -42.3% |
| Q4 2022 | $19,787,139 | +4210.9% | 543,006 | +17501.5% | 0.07% | +7000.0% |
| Q4 2021 | $459,000 | -93.9% | 3,085 | -94.1% | 0.00% | -96.3% |
| Q3 2021 | $7,584,000 | +44.1% | 52,094 | +93.8% | 0.03% | +42.1% |
| Q2 2021 | $5,263,000 | -44.8% | 26,879 | -49.0% | 0.02% | -54.8% |
| Q1 2021 | $9,537,000 | +14.9% | 52,693 | -10.1% | 0.04% | +16.7% |
| Q4 2020 | $8,300,000 | +19.2% | 58,617 | +5.0% | 0.04% | +33.3% |
| Q3 2020 | $6,961,000 | +22.7% | 55,833 | -12.1% | 0.03% | -6.9% |
| Q2 2020 | $5,674,000 | – | 63,535 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |